Cohen Cyril J, Sarig Offra, Yamano Yoshihisa, Tomaru Utano, Jacobson Steven, Reiter Yoram
Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
J Immunol. 2003 Apr 15;170(8):4349-61. doi: 10.4049/jimmunol.170.8.4349.
The advent in recent years of the application of tetrameric arrays of class I peptide-MHC complexes now enables us to detect and study rare populations of Ag-specific CD8(+) T cells. However, available methods cannot visualize or determine the number and distribution of these TCR ligands on individual cells nor detect APCs in tissues. In this study, we describe for the first time studies of human class I peptide-MHC ligand presentation. These studies were facilitated by applying novel tools in the form of peptide-specific, HLA-A2-restricted human recombinant Abs directed toward a viral epitope derived from human T cell lymphotropic virus type I. Using a large human Ab phage display library, we isolated a large panel of recombinant Fab Abs that are specific for a particular peptide-MHC class I complex in a peptide-dependent, MHC-restricted manner. We used these Abs to visualize the specific complex on APCs and virus-infected cells by flow cytometry, to quantify the number of, and visualize in situ, a particular complex on the surface of APCs bearing complexes formed by naturally occurring active intracellular processing of the cognate viral Ag. These findings demonstrate our ability to transform the unique fine specificity, but low intrinsic affinity of TCRs into high affinity soluble Ab molecules endowed with a TCR-like specificity toward human viral epitopes. These molecules may prove to be crucial useful tools for studying MHC class I Ag presentation in health and disease as well as for therapeutic purposes in cancer, infectious diseases, and autoimmune disorders.
近年来,I类肽 - MHC复合物四聚体阵列技术的出现,使我们能够检测和研究罕见的抗原特异性CD8(+) T细胞群体。然而,现有的方法无法可视化或确定这些TCR配体在单个细胞上的数量和分布,也无法检测组织中的抗原呈递细胞。在本研究中,我们首次描述了人类I类肽 - MHC配体呈递的研究。这些研究借助了新型工具,即针对源自I型人类嗜T细胞病毒的病毒表位的肽特异性、HLA - A2限制性人类重组抗体。利用大型人类抗体噬菌体展示文库,我们分离出了一大组重组Fab抗体,它们以肽依赖性、MHC限制性方式特异性识别特定的肽 - MHC I类复合物。我们使用这些抗体通过流式细胞术可视化抗原呈递细胞和病毒感染细胞上的特异性复合物,定量抗原呈递细胞表面特定复合物的数量并进行原位可视化,这些复合物是由同源病毒抗原的天然活跃细胞内加工形成的。这些发现证明了我们将TCR独特的精细特异性但低内在亲和力转化为对人类病毒表位具有TCR样特异性的高亲和力可溶性抗体分子的能力。这些分子可能被证明是研究健康和疾病中MHC I类抗原呈递以及用于癌症、传染病和自身免疫性疾病治疗目的的关键有用工具。
Proc Natl Acad Sci U S A. 2024-5-28
Antibodies (Basel). 2019-5-9
J Hematol Oncol. 2019-9-14